Clinical Trial Update: Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining whether vildagliptin affects glucagon response during hypoglycemia in Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Lund University | Conditions: Diabetes, Hypoglycemia | Phase 4 | Status: COMPLETED